![](http://cplbio.com/wp-content/uploads/2024/04/pdffile-icon.png)
Highlights:
Novavax Announces New Capital Infusion through a Strategic Alliance with Cadila Pharmaceuticals of India
Joint Venture to be funded by Cadila Pharmaceuticals and Revenues from Sales of Biogenerics; Deal Includes $11 Million Capital Investment in Novavax